Crucial steps in the natural history of inflammatory bowel disease.
about
Novel biomarkers of fibrosis in Crohn's diseaseCytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDMagnetic resonance enterography or video capsule endoscopy - what do Crohn's disease patients prefer?Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activationAnti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced ColitisPartners of patients with inflammatory bowel disease: how important is their support?Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel DiseaseInvestigation of inflammation and tissue patterning in the gut using a Spatially Explicit General-purpose Model of Enteric Tissue (SEGMEnT).Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysisCrohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.The Intersection of TNF, IBD and the Microbiome.Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study.First diagnosis of inflammatory bowel disease in a 91-year-old manThe -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysisRole of Salmonella enterica exposure in Chilean Crohn's disease patients.Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel diseaseThe role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measuresDysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.Hydroxylases as therapeutic targets in inflammatory bowel disease.Cellular and Molecular Mediators of Intestinal Fibrosis.Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies.Mechanisms of initiation and progression of intestinal fibrosis in IBD.The -A2518G polymorphism in the MCP-1 gene and inflammatory bowel disease risk: A meta-analysis.Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways.Pneumoperitoneum, pneumoretroperitoneum, pneumomediastinum and extensive subcutaneous emphysema in a patient with ulcerative colitis: A case report.Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation.Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn's Disease-associated Strictures-A Cohort Study.Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR) That Is Blocked by Interleukin-10
P2860
Q26738287-58C517C3-6ED1-4773-ABAD-6B7644321353Q26740540-6FF1A977-2A15-4ABC-A0EF-12DA80836549Q27335933-A0423FF1-5885-4C9A-AEBD-CFD82FC6696BQ28539497-A4D6F40C-C531-4D1F-9C43-782A3B793170Q33564081-4CEAB1E0-4833-457C-935B-0C0DE816DB2DQ33726361-13548FA2-E827-4985-9715-9626668B3799Q34004075-9C4E89F4-9669-4200-A55A-68B23B3E5526Q35056003-D3B0B7CC-F545-4B0C-82B0-0B6BDD4DDBC8Q35133364-111ABEF1-3741-4783-88E0-F977C4D3C05BQ35305303-5BEF2E6D-2583-42FC-9AA3-410AB4ACB617Q35933419-D45BD880-4AF3-4305-AE3E-BFD9852B9FC7Q35945255-A2B641C8-5A84-41A1-BD73-6E4E6ABDB753Q36480443-D47A9E41-7BF5-4B5F-A64E-D26CEC6F8F6FQ36551411-CAEF9B11-3666-4D37-85AC-D3B95547B8C2Q37007163-15C5DCB7-3381-4B3B-A46D-F0EF29D09070Q37221518-77033252-312B-4E46-8FFA-C4B73A84A0A0Q37260690-034D1E4B-0300-4000-BABA-0D0DA5311D82Q37260906-6687FF9D-45CC-4EE6-85E1-439EEF8CC1F1Q37660688-27F6344F-CA85-4BB0-B0A1-AC7C2F980B79Q38082620-EE4522E9-0B50-436E-B324-DF79D2C64772Q38259227-70CD3C30-BF19-41A4-8E9F-A6EF82201001Q38291952-11772FA7-B0B6-443B-9FD4-561E39EC8911Q38293779-594B7894-FF2A-44A8-BE99-BFBE7E3460C4Q38332079-A5A45201-C7F6-4A41-AD5F-B3B1E1AE5C1EQ38683067-7E3959AC-F7C5-42F6-A055-7C69FE613C9CQ39114030-87A25DC4-1289-4089-9AE9-5B899FE25221Q39280694-8A7BBFC8-CD2D-4C91-BD53-8F3BB49E9753Q41661053-D469BBC6-C2EF-4BF7-A43B-BB22500AE6E0Q42078064-47690131-61E3-4E80-8DC7-50976FA0F0CDQ44086481-D957C868-F5A3-4F79-9196-9D0980F3FBAFQ48020052-F37B7505-2EBB-4585-93E9-5889B7D255C1Q58701708-3CEFC83C-8F0D-4ECA-AFFA-0EC9D3DFEE30
P2860
Crucial steps in the natural history of inflammatory bowel disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Crucial steps in the natural history of inflammatory bowel disease.
@ast
Crucial steps in the natural history of inflammatory bowel disease.
@en
type
label
Crucial steps in the natural history of inflammatory bowel disease.
@ast
Crucial steps in the natural history of inflammatory bowel disease.
@en
prefLabel
Crucial steps in the natural history of inflammatory bowel disease.
@ast
Crucial steps in the natural history of inflammatory bowel disease.
@en
P2860
P356
P1476
Crucial steps in the natural history of inflammatory bowel disease
@en
P2093
Claudio Papi
P2860
P304
P356
10.3748/WJG.V18.I29.3790
P407
P577
2012-08-01T00:00:00Z